Author

Ke Meng

University Medical Center FreiburgORCID 0000-0002-2460-4728Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Alexandra Emilia SchlaakiD· 1 shared Anna Lena Stippel· 1 shared Bertram BengschiD· 1 shared Charlotte Marie NiemeyeriD· 1 shared Christian FlothoiD· 1 shared Daniel B. LipkaiD· 1 shared Hui XiaoiD· 1 shared Jovana RajakiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra Emilia SchlaakORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 1, 2025

Oncogenic PTPN11/SHP2 drives immune escape in juvenile myelomonocytic leukemia (JMML) through activation of ectonucleotidase/adenosine signaling

Jovana Rajak, Ke Meng, Anna Lena Stippel…·Miriam Erlacher

This study identifies PTPN11/SHP2-driven adenosine signaling as a mechanism of immune escape in JMML, showing that CD39 inhibition can enhance T cell responses and reduce myeloproliferation.

DOI 10.1101/2025.10.01.679664

mousebulk RNA-seq